GRSIX
Price
$10.88
Change
+$0.05 (+0.46%)
Updated
Jul 25 closing price
Net Assets
67.37M
VCRCX
Price
$14.42
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Net Assets
1.03B
Interact to see
Advertisement

GRSIX vs VCRCX

Header iconGRSIX vs VCRCX Comparison
Open Charts GRSIX vs VCRCXBanner chart's image
Brookfield Next Generation Infras I
Price$10.88
Change+$0.05 (+0.46%)
VolumeN/A
Net Assets67.37M
NYLI CBRE Global Infrastructure
Price$14.42
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.03B
GRSIX vs VCRCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GRSIX vs. VCRCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRSIX is a Buy and VCRCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRCX has more cash in the bank: 1.03B vs. GRSIX (67.4M). GRSIX pays higher dividends than VCRCX: GRSIX (1.19) vs VCRCX (1.02). GRSIX was incepted earlier than VCRCX: GRSIX (3 years) vs VCRCX (6 years). VCRCX (2.10) is less costly to investors than GRSIX (1.39). GRSIX is a more actively managed with annual turnover of: 69.00 vs. VCRCX (47.00). VCRCX has a lower initial minimum investment than GRSIX: VCRCX (1000) vs GRSIX (1000000). GRSIX annual gain was more profitable for investors over the last year : 19.52 vs. VCRCX (15.64).
GRSIXVCRCXGRSIX / VCRCX
Total Expense Ratio1.002.0848%
Annual Report Gross Expense Ratio1.392.1066%
Fund Existence3 years6 years-
Gain YTD23.38611.755199%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets67.4M1.03B7%
Annual Yield % from dividends1.191.02117%
Returns for 1 year19.5215.64125%
Returns for 3 years16.8418.2292%
Returns for 5 yearsN/A36.69-
Returns for 10 years-54.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PURE0.07N/A
+3.88%
PURE Bioscience
LTMCF0.43N/A
+0.44%
Lithium Chile Inc.
ORKLF10.73N/A
N/A
Orkla ASA
PHMMF92.57N/A
N/A
Pharma Mar SA
KYCCF395.74-10.01
-2.47%
Keyence Corp.